Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Home
Experts
Research units
Research output
Datasets
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
Low-molecular-weight heparin for prosthetic heart valves: Treatment failure
Oren Lev-Ran
, Amir Kramer
, Jacob Gurevitch
,
Itzhak Shapira
,
Rephael Mohr
*
*
Corresponding author for this work
Tel Aviv Sourasky Medical Center
Research output
:
Contribution to journal
›
Article
›
peer-review
112
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Low-molecular-weight heparin for prosthetic heart valves: Treatment failure'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Treatment Failure
100%
Heart Valve Prosthesis
100%
Low Molecular Weight Heparin
100%
Valve Treatment
100%
Clinical Presentation
25%
Warfarin
25%
Anticoagulation
25%
Thrombosis
25%
Successful Treatment
25%
Withholding
25%
Valve Replacement
25%
Heparin Therapy
25%
Unfractionated Heparin
25%
Nursing and Health Professions
Low Molecular Weight Heparin
100%
Treatment Failure
100%
Heart Valve Prosthesis
100%
Warfarin
25%
Anticoagulation
25%
Heparin
25%
Heart Valve Replacement
25%
Medicine and Dentistry
Low Molecular Weight Heparin
100%
Heart Valve Prosthesis
100%
Warfarin
25%
Anticoagulation
25%
Heparin
25%
Valve Replacement
25%
Pharmacology, Toxicology and Pharmaceutical Science
Low Molecular Weight Heparin
100%
Warfarin
33%
Heparin
33%